Mast cells and c-Kit expression in liver allograft rejection

被引:11
作者
El-Refaie, AMA [1 ]
Burt, AD [1 ]
机构
[1] Univ Newcastle Upon Tyne, Sch Clin & Lab Sci, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
关键词
acute rejection; chronic rejection; c-Kit; immunohistochemistry; liver transplantation; mast cells; tryptase;
D O I
10.1111/j.1365-2559.2005.02239.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: The pathogenesis of rejection following liver transplantation is not fully understood. It has been postulated that mast cells may play a role in acute and chronic rejection of a number of other solid organ grafts. The aim of this study was to assess the possible role of mast cells and c-Kit+ cells in acute and chronic liver allograft rejection. Methods and results: Biopsy specimens from (i) 'time zero' grafts with a minimal degree of perfusion injury (controls), (ii) transplanted livers with different grades of acute rejection, and (iii) transplanted livers with end-stage chronic rejection, were stained immunohistochemically using monoclonal anti-mast cell tryptase and polyclonal anti-c-Kit antibodies. Tryptase- and c-Kit-positive cell densities were assessed by image analysis. Tryptase-postive mast cell densities (P < 0.001) were strongly correlated with acute liver allograft rejection grades and chronic liver allograft rejection. Furthermore, a similarly strong relationship was found between c-Kit+ cell densities and increasing rejection grade (P < 0.001). Conclusions: Tryptase- and c-Kit-positive mast cells form part of the inflammatory infiltrate in both acute and chronic liver allograft rejection, and may be important effector cells in these processes.
引用
收藏
页码:375 / 381
页数:7
相关论文
共 34 条
[1]   Early human renal allograft fibrosis: Cellular mediators [J].
Abo-Zenah, H ;
Katsoudas, S ;
Wild, G ;
de Takats, D ;
Shortland, J ;
Brown, CB ;
El Nahas, AM .
NEPHRON, 2002, 91 (01) :112-119
[2]   Intrahepatic mast cell population correlates with clinical outcome in biliary atresia [J].
Ahmed, AFKU ;
Ohtani, H ;
Nio, M ;
Funaki, N ;
Sasaki, H ;
Nagura, H ;
Ohi, R .
JOURNAL OF PEDIATRIC SURGERY, 2000, 35 (12) :1762-1765
[3]  
ALBERTUS WW, 2003, ARCH MED RES, V34, P461
[4]   Mast cells distribution in human liver disease and experimental rat liver fibrosis. Indications for mast cell participation in development of liver fibrosis [J].
Armbrust, T ;
Batusic, D ;
Ringe, B ;
Ramadori, G .
JOURNAL OF HEPATOLOGY, 1997, 26 (05) :1042-1054
[5]   Activation of human mast cells through stem cell factor receptor (KIT) is associated with expression of bcl-2 [J].
Baghestanian, M ;
Jordan, JH ;
Kiener, HP ;
Bevec, D ;
Agis, H ;
Fritsch, G ;
Müller, MR ;
Bankl, HC ;
Schernthaner, GH ;
Lechner, K ;
Valent, P .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2002, 129 (03) :228-236
[6]  
Batts KP, 1999, LIVER TRANSPLANT SUR, V5, pS21
[7]   A NEW ACUTE TRANSFORMING FELINE RETROVIRUS AND RELATIONSHIP OF ITS ONCOGENE V-KIT WITH THE PROTEIN-KINASE GENE FAMILY [J].
BESMER, P ;
MURPHY, JE ;
GEORGE, PC ;
QIU, F ;
BERGOLD, PJ ;
LEDERMAN, L ;
SNYDER, HW ;
BRODEUR, D ;
ZUCKERMAN, EE ;
HARDY, WD .
NATURE, 1986, 320 (6061) :415-421
[8]  
Demetris AJ, 1997, HEPATOLOGY, V25, P658
[9]   Neural immunoregulation: emerging roles for nerves in immune homeostasis and disease [J].
Downing, JEG ;
Miyan, JA .
IMMUNOLOGY TODAY, 2000, 21 (06) :281-289
[10]   INTRAHEPATIC MAST-CELLS IN CHRONIC LIVER-DISEASES [J].
FARRELL, DJ ;
HINES, JE ;
WALLS, AF ;
KELLY, PJ ;
BENNETT, MK ;
BURT, AD .
HEPATOLOGY, 1995, 22 (04) :1175-1181